Page 63 - OR-1-1

doi: 10.1038/nmeth.4537 doi: 10.1038/nprot.2015.088
78. Roh TT, Alex A, Chandramouleeswaran PM, et al. Predicting 89. Schmidt S. Autism in three dimensions: Using brain
DNA damage response in non-small cell lung cancer organoids to study potential gene-environment interactions.
organoids via simultaneous label-free autofluorescence Environ Health Perspect. 2021;129:104003.
multiharmonic microscopy. Redox Biol. 2024;75:103280.
doi: 10.1289/EHP10301
doi: 10.1016/j.redox.2024.103280
90. Menche C, Farin HF. Strategies for genetic manipulation
79. Yildirim M, Delepine C, Feldman D, et al. Label-free three- of adult stem cell-derived organoids. Exp Mol Med.
photon imaging of intact human cerebral organoids for 2021;53:1483-1494.
tracking early events in brain development and deficits in
Rett syndrome. Elife. 2022;11:e78079. doi: 10.1038/s12276-021-00609-8
91. Kim GA, Ginga NJ, Takayama S. Integration of sensors in
doi: 10.7554/eLife.78079
gastrointestinal organoid culture for biological analysis. Cell
80. Mao W, Bui HTD, Cho W, Yoo HS. Spectroscopic techniques Mol Gastroenterol Hepatol. 2018;6:123-131.e121.
for monitoring stem cell and organoid proliferation in 3D
environments for therapeutic development. Adv Drug Deliv doi: 10.1016/j.jcmgh.2018.03.002
Rev. 2023;201:115074. 92. Le Floch P, Li Q, Lin Z, et al. Stretchable mesh nanoelectronics
doi: 10.1016/j.addr.2023.115074 for 3D single‐cell chronic electrophysiology from developing
brain organoids. Adv Mater. 2022;34:2106829.
81. Walsh AJ, Cook RS, Skala MC. Functional optical imaging
of primary human tumor organoids: Development of a doi: 10.1002/adma.202106829
personalized drug screen. J Nucl Med. 2017;58:1367-1372. 93. Yin J, Lees JG, Gong S, et al. Real-time electro-mechanical
doi: 10.2967/jnumed.117.192534 profiling of dynamically beating human cardiac organoids
by coupling resistive skins with microelectrode arrays.
82. Beghin A, Grenci G, Sahni G, et al. Automated high-speed Biosensors Bioelectron. 2025;267:116752.
3D imaging of organoid cultures with multi-scale phenotypic
quantification. Nat Methods. 2022;19:881-892. doi: 10.1016/j.bios.2024.116752
doi: 10.1038/s41592-022-01508-0 94. Schaumann EN., Tian B. Biological interfaces, modulation,
and sensing with inorganic nano‐bioelectronic materials.
83. Hendriks D, Artegiani B, Hu H, Chuva de Sousa Lopes S, Small Methods. 2020;4:1900868.
Clevers H. Establishment of human fetal hepatocyte
organoids and CRISPR-Cas9-based gene knockin and doi: 10.1002/smtd.201900868
knockout in organoid cultures from human liver. Nat Protoc. 95. Costanzo M, Cutrona C, Leodori C, et al. Exploring easily
2021;16:182-217. accessible neurophysiological biomarkers for predicting
doi: 10.1038/s41596-020-00411-2 Alzheimer’s disease progression: A systematic review.
Alzheimers Res Ther. 2024;16:244.
84. Thorel L, Perréard M, Florent R, et al. Patient-derived
tumor organoids: A new avenue for preclinical research doi: 10.1186/s13195-024-01607-4
and precision medicine in oncology. Exp Mol Med. 2024;56: 96. Liu H, Gan Z, Qin X, Wang Y, Qin J. Advances in microfluidic
1531-1551. technologies in organoid research. Adv Healthc Mater.
doi: 10.1038/s12276-024-01272-5 2024;13:2302686.
85. Matano M, Date S, Shimokawa M, et al. Modeling colorectal doi: 10.1002/adhm.202302686
cancer using CRISPR-Cas9-mediated engineering of 97. Vogt N. Assembloids. Nat Methods. 2021;18:27.
human intestinal organoids. Nat Med. 2015;21:256-262.
doi: 10.1038/nm.3802 doi: 10.1038/s41592-020-01026-x
86. Chen F, Lian M, Ma B, et al. Multiplexed base editing through 98. Miura Y, Li MY, Revah O, Yoon SJ, Narazaki G, Pașca SP.
Cas12a variant-mediated cytosine and adenine base editors. Engineering brain assembloids to interrogate human neural
Commun Biol. 2022;5:1163. circuits. Nat Protoc. 2022;17:15-35.
doi: 10.1038/s42003-022-04152-8 doi: 10.1038/s41596-021-00632-z
87. Zafra MP, Schatoff EM, Katti A, et al. Optimized base editors 99. Günther C, Winner B, Neurath MF, Stappenbeck TS.
enable efficient editing in cells, organoids and mice. Nat Organoids in gastrointestinal diseases: From experimental
Biotechnol. 2018;36:888-893. models to clinical translation. Gut. 2022;71:1892-1908.
doi: 10.1038/nbt.4194 doi: 10.1136/gutjnl-2021-326560
88. Fujii M, Matano M, Nanki K, Sato T. Efficient genetic 100. Andersen J, Revah O, Miura Y, et al. Generation of functional
engineering of human intestinal organoids using human 3D cortico-motor assembloids. Cell. 2020;183:1913-
electroporation. Nat Protoc. 2015;10:1474-1485. 1929.e1926.

Volume 1 Issue 1 (2025) 16 doi: 10.36922/OR025040007